Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Biol Pharm Bull ; 30(6): 1042-7, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17541151

RESUMO

It is known that rheumatoid arthritis (RA) accelerates atherosclerosis. Further, the soluble form of vascular adhesion molecule-1 (VCAM-1) is known as a predictive marker of atherosclerosis in RA patients. We reported that keishibukuryogan, one of the Kampo formulas, improved articular symptoms and decreased soluble VCAM-1 in patients with RA. In adjuvant-induced arthritis (AIA) rats, an animal model of RA, it is known that endothelial function is injured by inflammation. So, we investigated the effect of keishibukuryogan on endothelial function in AIA rats. Lewis rats were divided into control, AIA control, and AIA with keishibukuryogan groups. The AIA with keishibukuryogan group was fed 3% keishibukuryogan contained in normal chow. On day 25 after injection of Mycobacterium butyricum, endothelium-dependent relaxation by acetylcholine in the AIA control group was suppressed, but it was improved in the AIA with keishibukuryogan group. The contractions by xanthine/xanthine oxidase in both AIA rats increased, but that in keishibukuryogan decreased compared to the AIA control group. Plasma levels of lipid peroxide increased in the AIA control group, but keishibukuryogan decreased these levels. Plasma levels of nitric oxide (NO) increased in both AIA groups. The expressions of endothelial NO synthase, inducible NO synthase and VCAM-1 of thoracic aorta were investigated by western blotting. These expressions increased in the AIA control group, but were restricted in the AIA with keishibukuryogan group. We considered that keishibukuryogan protected the endothelial function of AIA rats mainly by its anti-oxidative effect.


Assuntos
Antioxidantes/farmacologia , Artrite Experimental/metabolismo , Medicamentos de Ervas Chinesas/farmacologia , Endotélio Vascular/efeitos dos fármacos , Medicina Kampo , Acetilcolina/farmacologia , Animais , Aorta Torácica/enzimologia , Aorta Torácica/metabolismo , Artrite Experimental/induzido quimicamente , Artrite Experimental/fisiopatologia , Adjuvante de Freund , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Óxido Nítrico/sangue , Óxido Nítrico Sintase Tipo II/metabolismo , Óxido Nítrico Sintase Tipo III/metabolismo , Perfusão , Distribuição Aleatória , Ratos , Ratos Endogâmicos Lew , Molécula 1 de Adesão de Célula Vascular/metabolismo , Vasodilatadores/farmacologia , Xantina/farmacologia , Xantina Oxidase/farmacologia
2.
Evid Based Complement Alternat Med ; 3(3): 359-64, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16951720

RESUMO

An increasing death rate due to cardiovascular disease in patients with rheumatoid arthritis (RA) has been reported. Keishibukuryogan (KBG) is a traditional Chinese/Japanese (Kampo) formula that has been administered to patients with blood stagnation, e.g. thrombotic disease and atherosclerosis. The objective of this study was to evaluate the efficacy of KBG on disease activity and endothelial dysfunction in RA patients. Sixteen RA patients were enrolled and administered KBG (12 g per day) for 12 weeks in addition to continuing other drugs. The disease activity of RA was assessed by modified disease activity scores for 28 joints (DAS(28)). Plasma levels of adhesion molecules, soluble E-selectin (sE-selectin), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were evaluated. C-reactive protein (CRP), inflammatory cytokines (IL-1beta, IL-6 and TNF-alpha) and lipid peroxide (LPO) were also evaluated. Fourteen patients completed the study. The disease activity of RA, tender joint count, swollen joint count and DAS(28) decreased significantly. Among adhesion molecules, only sVCAM-1 decreased significantly. LPO also decreased significantly, whereas CRP and inflammatory cytokines remained unchanged. These results suggest that KBG has insufficient anti-inflammatory or immunomodulating effect but does have a beneficial effect on articular symptoms and a protective effect against endothelial dysfunction in RA patients.

3.
Biol Pharm Bull ; 28(5): 817-21, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15863885

RESUMO

Chuling, sclerotia of Polyporus umbellatus FRIES, has long been used for urological disorders in traditional medicine. In this study, we demonstrated that Chuling in vitro protects red blood cells from 2,2-azo-bis(2-amidinopropane)dihydrochloride (AAPH)-induced hemolysis. The inhibitory effect was dose-dependent at concentrations of 50 to 1000 microg/ml. Moreover, tests were carried out to identify the main ingredient of Chuling with scavenging effect on free radicals. Triterpene carboxylic acids isolated from the methanol extract of Chuling, namely, polyporusterone A and polyporusterone B, were found to have inhibitory activities against AAPH-induced lysis of red blood cells. The anti-hemolytic effect was significantly stronger in polyporusterone B compared with polyporusterone A. Furthermore, the ingestion of 150 mg of Chuling was associated with a significant increase in free-radical scavenging effect of plasma in rats.


Assuntos
Eritrócitos/efeitos dos fármacos , Radicais Livres/antagonistas & inibidores , Hemólise/efeitos dos fármacos , Polyporales , Triterpenos/farmacologia , Relação Dose-Resposta a Droga , Eritrócitos/metabolismo , Sequestradores de Radicais Livres/isolamento & purificação , Sequestradores de Radicais Livres/farmacologia , Radicais Livres/farmacologia , Hemólise/fisiologia , Humanos , Masculino , Polyporales/isolamento & purificação , Triterpenos/isolamento & purificação
4.
Hum Psychopharmacol ; 19(4): 235-41, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15181651

RESUMO

OBJECTIVE: To evaluate the efficacy of a herbal medicine (Mao-to) on psychiatric complications caused by IFN, and to examine the relationship between depression and microcirculation. METHODS: Twelve patients with chronic hepatitis C and a past history of IFN-induced depression were enrolled in this study. Their mental state was evaluated by the self-rating depression scale (SDS)> or =40, or M-R of the Cornell medical index (CMI)> or =10. Each patient received a daily dose of 6 million units of IFN-beta for 8 weeks, and Mao-to was given orally four times a day during the IFN-beta course. RESULTS: All patients in this study completed a full course of IFN. Mean CMI scores (M-R) had significantly decreased at the end of the treatment. Mean erythrocyte aggregability and erythrocyte deformability had also significantly decreased at the end of treatment. CONCLUSION: Mao-to might be useful for preventing the incidence of depression in patients with chronic hepatitis C being treated with IFN. The mechanism by which Mao-to prevents depression is suggested to be through the improvement of microcirculation.


Assuntos
Antivirais/efeitos adversos , Transtorno Depressivo/prevenção & controle , Medicamentos de Ervas Chinesas/uso terapêutico , Hepatite C Crônica/tratamento farmacológico , Interferon beta/efeitos adversos , Fitoterapia , Adulto , Idoso , Antivirais/uso terapêutico , Cromatografia Líquida de Alta Pressão , Transtorno Depressivo/etiologia , Agregação Eritrocítica/efeitos dos fármacos , Deformação Eritrocítica/efeitos dos fármacos , Feminino , Hepatite C Crônica/sangue , Hepatite C Crônica/fisiopatologia , Humanos , Interferon beta/uso terapêutico , Masculino , Microcirculação/efeitos dos fármacos , Pessoa de Meia-Idade , Projetos Piloto , Escalas de Graduação Psiquiátrica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA